Insights to SARS-CoV-2 life cycle, pathophysiology, and rationalized treatments that target COVID-19 clinical complications
Crossref DOI link:
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
Trougakos, Ioannis P.
Tsitsilonis, Ourania E.
Pavlakis, George N.
Dimopoulos, Meletios A.
Text and Data Mining valid from 2021-01-12
Version of Record valid from 2021-01-12
5 October 2020
23 December 2020
12 January 2021
Ethics approval and consent to participate
The authors declare that they have no competing interests for this article.